Dr. Botond Roska says we should keep our eyes on gene therapy.
Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.
Physician-scientist Cyndy Grosskreutz explains why she transitioned from academia to industry.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.